Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.470
-0.020 (-1.34%)
Jun 1, 2026, 10:28 AM EDT - Market open

PACB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4575655392,6271,8534,521
Market Cap Growth
38.32%4.80%-79.49%41.76%-59.02%-9.36%
Enterprise Value
887.01987.13811.262,9192,0184,423
Last Close Price
1.471.871.839.818.1820.46
PS Ratio
2.853.533.5013.1014.4434.64
PB Ratio
195.54105.561.063.753.295.72
P/TBV Ratio
187.75104.871.043.553.265.28
EV/Sales Ratio
5.546.175.2714.5615.7333.89
Debt / Equity Ratio
297.17131.241.311.321.671.20
Net Debt / Equity Ratio
180.6579.060.560.430.31-0.11
Net Debt / EBITDA Ratio
-3.59-2.47-0.65-0.96-0.590.45
Net Debt / FCF Ratio
-3.68-3.71-1.33-1.13-0.620.77
Asset Turnover
0.200.160.100.110.070.11
Inventory Turnover
1.982.021.862.722.093.67
Quick Ratio
4.674.326.307.033.0014.90
Current Ratio
5.655.157.487.813.2415.36
Return on Equity (ROE)
-3333.14%-213.45%-51.30%-48.53%-46.42%-32.18%
Return on Assets (ROA)
-17.12%-54.21%-31.59%-18.36%-16.28%-11.46%
Return on Invested Capital (ROIC)
-29.51%-86.49%-50.37%-32.18%-32.94%-28.04%
Return on Capital Employed (ROCE)
-18.66%-58.14%-33.34%-21.20%-17.87%-18.21%
Buyback Yield / Dilution
-7.43%-4.02%-13.70%-12.95%-10.00%-16.67%
Total Shareholder Return
-7.43%-4.02%-13.70%-12.95%-10.00%-16.67%
SEC Filings: 10-K · 10-Q